Advanced Solid Tumors Clinical Trials

There are 13 registered clinical trials for Advanced Solid Tumors in the TrialLens index.

Trials (13)

• A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors Phase 1 · Sanofi
• Lenalidomide and Paclitaxel in Advanced Solid Tumors Phase 1 · Southern Europe New Drug Organization
• A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors Phase 1 · AbbVie
• Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors Phase 1 · Guangzhou Gloria Biosciences Co., Ltd.
• A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors Phase 1/2 · Lepu Biopharma Co., Ltd.
• A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors Phase 1 · Qilu Pharmaceutical Co., Ltd.
• First in Human Trial of TAS266 in Patients With Advanced Solid Tumors Phase 1 · Novartis Pharmaceuticals
• A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body Phase 1 · Astellas Pharma Global Development, Inc.
• GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies Phase 1/2 · GI Cell, Inc.
• Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS Phase 1/2 · Betta Pharmaceuticals Co., Ltd.
• A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors Phase 1/2 · DualityBio Inc.
• KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma) Phase 1 · TCRx Therapeutics Co.Ltd
• A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer Phase 1 · Georgetown University

Related landscapes

• Phase 1/2 Advanced Solid Tumors
• Phase 1 Advanced Solid Tumors

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.